Cancer Molecular Pathology Training Program

癌症分子病理学培训项目

• 批准号: 6514695
• 负责人: FREDERIC G BARR
• 金额: $ 36.19万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-06-06 至 2006-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6514695
• 关键词: curriculum; education evaluation /planning; molecular pathology; neoplasm /cancer education; neoplasm /cancer genetics; training

DESCRIPTION (provided by applicant): The overall goal of the field of cancer molecular pathology is the identification, analysis, and application of molecular markers relevant to cancer susceptibility, diagnosis, prognosis, monitoring, or therapy. As this young interdisciplinary field grows and evolves, there is a clear need to develop novel mechanisms to provide customized training experiences for postdoctoral physician-scientists. These training experiences need to provide a strong educational background that stresses the interrelationships among the participating disciplines that include tumor biology, pathology, oncology, genetics, and quantitative biology. Furthermore, such training experiences must provide in-depth exposure to an interdisciplinary research environment that requires interactive collaboration among biologists, pathologists, oncologists, and other specialists. To create this important training mechanism at the University of Pennsylvania, the Department of Pathology and Laboratory Medicine in conjunction with the University of Pennsylvania Cancer Center is proposing the implementation of a Cancer Molecular Pathology Training Program. The objective of this training program is to permit individuals with clinical training in pathology, oncology, or related fields to obtain basic education and develop research skills necessary for the validation and translation of cancer molecular information into clinical tests for cancer risk assessment, screening, diagnosis, prognosis, minimal disease assessment and therapeutic response prediction. These interdisciplinary didactic and research experiences will be facilitated by organization of a program faculty consisting of tumor biologists, pathologists, oncologists, molecular geneticists, and quantitative biologists. Trainees of this program will be prepared for an academic career in cancer molecular pathology by: 1) coursework in a specialized curriculum; 2) research training that involves completion of an interdisciplinary research project under the supervision of multiple mentors from the participating disciplines; and 3) publication, presentation and grantsmanship training. This innovative program will build on the considerable existing strengths at the University of Pennsylvania in pathology, genetics and cancer, with an established environment of interdisciplinary interactions among the Department of Pathology and Laboratory Medicine, the Cancer Center, the Center for Clinical Epidemiology and Biostatistics and other academic units.

描述（由申请人提供）：癌症领域的总体目标 分子病理学是鉴定、分析和应用 与癌症易感性、诊断、预后相关的分子标志物， 监测或治疗。 随着这个年轻的跨学科领域的发展， 发展，显然需要开发新的机制，以提供 为博士后医生-科学家提供定制的培训经验。 这些 培训经验需要提供强大的教育背景， 强调参与学科之间的相互关系， 包括肿瘤生物学、病理学、肿瘤学、遗传学和定量 生物学 此外，这种培训经验必须提供深入的 接触跨学科的研究环境，需要 生物学家、病理学家、肿瘤学家和 其他专家。 为了建立这一重要的培训机制， 宾夕法尼亚大学病理学和实验室系 医学与宾夕法尼亚大学癌症中心合作， 建议实施癌症分子病理学培训计划。 该培训计划的目标是允许个人与临床 接受病理学、肿瘤学或相关领域的培训，以获得基础教育 并发展必要的研究技能，以验证和翻译 将癌症分子信息转化为癌症风险评估的临床测试， 筛查、诊断、预后、微小疾病评估和治疗 响应预测 这些跨学科的教学和研究 经验将通过组织一个程序教师促进 包括肿瘤生物学家、病理学家、肿瘤学家、分子生物学家、 遗传学家和定量生物学家。 该计划的学员将 为癌症分子病理学的学术生涯做好准备：1） 专业课程中的课程作业; 2）涉及 在监督下完成跨学科研究项目 来自参与学科的多位导师;以及3）出版物， 介绍和培训。 这项创新计划将建立 宾夕法尼亚大学现有的相当大的优势， 病理学、遗传学和癌症， 病理学系之间的跨学科互动， 检验医学、癌症中心、临床流行病学中心 生物统计学和其他学术单位。